Article citationsMore>>

O’Connor, C.M., Jiang, W., Kuchibhatla, M., Silva, S.G., Cuffe, M.S., Callwood, D.D., Zakhary, B., Stough, W.G., Arias, R.M., Rivelli, S.K., et al. (2010) Safety and Efficacy of Sertraline for Depression in Patients with Heart Failure: Results of the SADHART-CHF (Sertraline against Depression and Heart Disease in Chronic Heart Failure) Trial. J Am Coll Cardiol, 56, 692-699. https://doi.org/10.1016/j.jacc.2010.03.068

has been cited by the following article:

• TITLE: Cognitive Behavior Therapy for Heart Failure Patients with Depression

  AUTHORS: Shancy Shabu, Rasika Jayasekara

  KEYWORDS: Heart Failure, Depression, Cognitive Behavior Therapy, Systematic Review

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.7 No.5, May 17, 2019

  ABSTRACT: The purpose of this systematic review was to examine the effectiveness of cognitive behavior therapy (CBT) in minimizing the depressive symptoms and improving quality of life in heart failure (HF) patients with depression. This systematic review was conducted in accordance with the Joanna Briggs Institute methodology for systematic reviews of effectiveness evidence. This review only considered randomized controlled trial, assessing the effectiveness of CBT as a treatment for depression in adults (aged above 18) with HF, compared with usual care, which may include medications. This systematic review includes five RCTs involving 379 HF patients with depression (CBT = 192; Control = 187). Two RCTs compared CBT versus usual care using BDI, and no statistically significant differences were observed in reduction of depression after three months of the intervention (MD ?0.92, 95% CI ?1.89 to ?0.05) (p = 0.06). However, a significant difference of depression level was identified between CBT and control groups in a meta-analysis of two RCTs after 6-months of intervention measured by Hamilton Depression Scale (HAM-D) (MD ?3.34, 95% CI ?5.00 to ?1.68) (p = 0.0001) with moderate heterogeneity (I2 = 43%). Quality of life was assessed at three months between intervening groups undergoing CBT and the control group with usual care in two RCTs. A statistically significant improvement was observed in the Minnesota Living with Heart Failure Questionnaire (MLHFQ) in the CBT group compared with usual care (MD ?9.44, 95% CI ?13.02 to ?5.87) (p